FindTrial
Sign In

The retrospective study of acute myeloid leukemia with RARG-rearrangement

The retrospective study of acute myeloid leukemia with RARG-rearrangement

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200055810
Enrollment
Unknown
Registered
2022-01-20
Start date
2022-01-10
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute myeloid leukemia

Interventions

AML with RARG-rearrangement:None

Sponsors

the First Affiliated Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 67 Years

Inclusion criteria

Inclusion criteria: 1. Newly diagnosed AML patients by WHO classification; 2. Leukemia fusion gene detected with RARG rearrangement.

Exclusion criteria

Exclusion criteria: AML patients without RARG rearrangements.

Design outcomes

Primary

MeasureTime frame
complete remission;Overall survival;event-free survival;the cumulative incidence of relapse;—

Countries

China

Contacts

Public ContactZhu Honghu

Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine

zhuhhdoc@163.com+86 13671322272

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026